Gemcitabine-associated DRESS syndrome: A case report
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2023/04/03
-
Indian UGC (journal)
-
Refrences19
-
Citations1
-
Ertugrul Bayram Department of Medical Oncology, Çukurova University Faculty of Medicine, Adana, Turkey ORCID (unauthenticated)
-
Tugba Toyran Department of Pathology, Çukurova University Faculty of Medicine, Adana, Turkey
-
Semra Paydas Department of Medical Oncology, Çukurova University Faculty of Medicine, Adana, Turkey ORCID (unauthenticated)
Abstract
Cite
Bayram, Ertugrul, et al. “Gemcitabine-Associated DRESS Syndrome: A Case Report”. Journal of Oncology Pharmacy Practice, vol. 29, no. 6, 2023, pp. 1480-3, https://doi.org/10.1177/10781552231167531.
Bayram, E., Toyran, T., & Paydas, S. (2023). Gemcitabine-associated DRESS syndrome: A case report. Journal of Oncology Pharmacy Practice, 29(6), 1480-1483. https://doi.org/10.1177/10781552231167531
Bayram E, Toyran T, Paydas S. Gemcitabine-associated DRESS syndrome: A case report. Journal of Oncology Pharmacy Practice. 2023;29(6):1480-3.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
- Epidemiology of Brain Metastases
- The Obesity Paradox in Cancer: a Review
- Obesity and Cancer Risk: Recent Review and Evidence
- SPIKES—A Six-Step Protocol for Delivering Bad News: Application to the Patient with Cancer
- FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Title | 2015 | |||
| Title | Case reports |
| 2011 | |
| Gemcitabine—a safety review | Anti-Cancer Drugs |
| 154 | 1998 |
| Gemcitabine: vascular toxicity and prothrombotic potential | Expert Opinion on Drug Safety |
| 99 | 2008 |
| 10.1200/JCO.1991.9.3.491 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Gemcitabine | Reactions Weekly | 2023 |